{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:53:37Z","timestamp":1791244417361,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.diagmicrobio.2026.117531","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:50:35Z","timestamp":1782543035000},"page":"117531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum HBV RNA reflects persistent viral transcriptional activity in nucleos(t)ide analogue-treated patients despite suppressed HBV DNA"],"prefix":"10.1016","volume":"116","author":[{"given":"Hongfang","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117531_bib0001","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117531_bib0002","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"European association for the study of the liver. EASL clinical practice guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117531_bib0003","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/hep.32479","article-title":"Circulating HBV RNA: from biology to clinical applications","volume":"76","author":"Deng","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117531_bib0004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3350\/cmh.2021.0283","article-title":"Approaches to quantifying hepatitis B virus covalently closed circular DNA","volume":"28","author":"Zhang","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.diagmicrobio.2026.117531_bib0005","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/acsinfecdis.8b00081","article-title":"Virological basis for the cure of chronic hepatitis B","volume":"5","author":"Hu","year":"2019","journal-title":"ACS Infect Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117531_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008945","article-title":"Biogenesis and molecular characteristics of serum hepatitis B virus RNA","volume":"16","author":"Shen","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.diagmicrobio.2026.117531_bib0007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3851\/IMP1508","article-title":"Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B","volume":"15","author":"Huang","year":"2010","journal-title":"Antivir Ther"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117531_bib0008","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2016.05.029","article-title":"Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound","volume":"65","author":"Wang","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2026.117531_bib0009","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcv.2017.12.016","article-title":"Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-na\u00efve HBV-infected individuals","volume":"99-100","author":"Huang","year":"2018","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2026.117531_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104553","article-title":"Non-invasive biomarkers for chronic hepatitis B virus infection management","volume":"169","author":"Charre","year":"2019","journal-title":"Antiviral Res"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117531_bib0011","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/jvh.12908","article-title":"Natural history of serum HBV-RNA in chronic HBV infection","volume":"25","author":"Wang","year":"2018","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117531_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12985-020-01471-2","article-title":"Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment","volume":"18","author":"Wang","year":"2021","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117531_bib0013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12876-019-0966-4","article-title":"Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117531_bib0014","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/gutjnl-2023-330644","article-title":"Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B","volume":"73","author":"Testoni","year":"2024","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117531_bib0015","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/hep.30325","article-title":"Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection","volume":"69","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2026.117531_bib0016","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijid.2020.07.031","article-title":"Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks","volume":"99","author":"Wang","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117531_bib0017","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/MEG.0000000000002946","article-title":"Predictive value of serum HBV RNA on HBeAg seroconversion in treated chronic hepatitis B patients","volume":"37","author":"Liu","year":"2025","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117531_bib0018","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00535-021-01812-0","article-title":"HBeAg-positive patients with HBsAg \u2009<\u2009100 IU\/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation","volume":"56","author":"Xie","year":"2021","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117531_bib0019","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/infdis\/jiae541","article-title":"Hepatitis B Virus RNA as a biomarker for safe antiviral discontinuation: a prospective study of nucleos(t)ide analogue withdrawal","volume":"231","author":"Terrault","year":"2025","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117531_bib0020","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s00535-012-0737-2","article-title":"Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients","volume":"48","author":"Tsuge","year":"2013","journal-title":"J Gastroenterol"},{"issue":"157","key":"10.1016\/j.diagmicrobio.2026.117531_bib0021","first-page":"119","article-title":"Serum HBV RNA levels predict significant liver fibrosis in patients with chronic HBV infection","volume":"29","author":"Huang","year":"2020","journal-title":"Discov Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117531_bib0022","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/jvh.13790","article-title":"Serum HBV RNA is associated with liver fibrosis regression in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues","volume":"30","author":"Bian","year":"2023","journal-title":"J Viral Hepat"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117531_bib0023","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.cgh.2020.03.001","article-title":"Persistent low level of Hepatitis B virus promotes fibrosis progression during therapy","volume":"18","author":"Sun","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"17","key":"10.1016\/j.diagmicrobio.2026.117531_bib0024","first-page":"32261","article-title":"Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients","volume":"S0168-8278","author":"Wang","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117531_bib0025","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/hep.31850","article-title":"HBV\/pregenomic RNA increases the stemness and promotes the development of HBV related HCC through reciprocal regulation with insulin-like growth factor 2 mRNA-binding protein 3","volume":"74","author":"Ding","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117531_bib0026","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.24809","article-title":"Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity","volume":"55","author":"Wang","year":"2012","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117531_bib0027","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.diagmicrobio.2026.117531_bib0028","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.20275","article-title":"Clinical value of serum HBV RNA in patients with chronic hepatitis B during antiviral therapy","volume":"13","author":"Zhang","year":"2025","journal-title":"PeerJ"},{"issue":"20","key":"10.1016\/j.diagmicrobio.2026.117531_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262010141","article-title":"Utility of serum HBV RNA measurement during nucleoside\/nucleotide analog therapy in chronic Hepatitis B patients","volume":"26","author":"Hiraoka","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117531_bib0030","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JCM.00760-17","article-title":"Serum hepatitis B Virus DNA, RNA, and HBsAg: which correlated better with intrahepatic covalently closed circular DNA before and after nucleos(t)ide analogue treatment?","volume":"55","author":"Gao","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117531_bib0031","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jmv.25925","article-title":"Serum HBV RNA composition dynamics as a marker for intrahepatic HBV cccDNA turnover","volume":"92","author":"Hong","year":"2020","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117531_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2485","article-title":"Histomolecular characterisation of hepatitis B virus induced liver cancer","volume":"33","author":"Adugna","year":"2023","journal-title":"Rev Med Virol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117531_bib0033","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jfma.2023.05.029","article-title":"Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy","volume":"122","author":"Kim","year":"2023","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117531_bib0034","first-page":"766","article-title":"Emerging serum biomarkers for chronic Hepatitis B: focus on serum HBV RNA and HBcrAg","volume":"13","author":"Tian","year":"2025","journal-title":"J Clin Transl Hepatol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326002816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326002816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:04:26Z","timestamp":1791241466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889326002816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0732889326002816"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117531","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum HBV RNA reflects persistent viral transcriptional activity in nucleos(t)ide analogue-treated patients despite suppressed HBV DNA","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117531"}}